Clozapine's unique efficacy in treatment-resistant schizophrenia is best explained by its receptor binding profile compared to typical antipsychotics. Which characteristic is most pharmacologically distinctive?
- A Irreversible D2 receptor blockade preventing receptor upregulation
- B Selective D1 partial agonism in prefrontal cortex without D2 blockade
- C Potent D3 antagonism in mesolimbic pathway with minimal D2 activity
- D High D4 > D2 antagonism combined with potent 5-HT2A, alpha-1, H1, and muscarinic M1/M4 antagonism with fast dissociation from D2 receptors ✓
Explanation
Clozapine has a loose, fast-dissociating ('hit-and-run') binding at D2 receptors combined with higher affinity for D4 receptors, 5-HT2A, 5-HT2C, alpha-1, H1, and M1/M4 muscarinic receptors. The fast D2 dissociation (transient occupancy hypothesis by Kapur) reduces EPS and tardive dyskinesia while the multi-receptor antagonism addresses negative symptoms and cognitive features. The strong 5-HT2A blockade disinhibits dopaminergic neurons in the prefrontal cortex, improving negative symptoms. This profile explains efficacy against positive AND negative symptoms of treatment-resistant schizophrenia.
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.